← Open Payments lookup

MIGUEL CORREA: Open Payments

NPI 1710198239 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$541 in 22 payments from 9 companies in 2025. Trend: 2023 $1,159 · 2024 $586 · 2025 $541

Food & beverage: $541
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$161
Braeburn Inc.4$106
Alkermes, Inc.3$75
Otsuka Pharmaceutical Development & Commercialization, Inc.2$48
ACADIA Pharmaceuticals Inc1$45
Teva Pharmaceuticals USA, Inc.2$41
Neurocrine BioSciences, Inc.1$27
Luye Pharma (USA) Ltd.1$23
Janssen Pharmaceuticals, Inc1$16

Products named: CAPLYTA, BRIXADI, REJOYN, VIVITROL, NUPLAZID, AUSTEDO XR, ARISTADA, INGREZZA.

Industry payments across FL — which companies pay providers there.